New Jersey Clinical Trials
Browse actively recruiting clinical trials with research sites in New Jersey. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in New Jersey
- Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)NCT06095583PHASE3Shanghai Junshi Bioscience Co., Ltd.Limited-stage Small Cell Lung Cancer (LS-SCLC)New Brunswick, NJ
- A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal CancerNCT07525206PHASE3AbbVieColorectal CancerEast Brunswick, NJ
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerEast Brunswick, NJ
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)NCT06667700PHASE3Merck Sharp & Dohme LLCCoronavirus Disease (COVID-19)Newark, NJ
- The ED-AWARENESS-2 TrialNCT05534243NAWashington University School of MedicineAwarenessCamden, NJ
- A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationNCT07441642PHASE2Novartis PharmaceuticalsGeographic Atrophy Secondary to Age-related Macular DegenerationToms River, NJ
- A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).NCT05947851PHASE3Merck Sharp & Dohme LLCLeukemia, Lymphocytic, Chronic, B-CellMorristown, NJ
- A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionNCT07128199PHASE3Taiho Oncology, Inc.Lung CancerBasking Ridge, NJ
- A Study to Learn About the Study Medicine PF-08052667 in People With Bladder CancerNCT07206225PHASE1PfizerNon-muscle Invasive Bladder CancerBasking Ridge, NJ
- Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune SystemNCT07042295PHASE2National Cancer Institute (NCI)Locally Recurrent Skin Squamous Cell CarcinomaBasking Ridge, NJ
- Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).NCT06641414PHASE3Ascentage Pharma Group Inc.Higher-risk Myelodysplastic SyndromeHackensack, NJ
- ALTO-100 in Bipolar Disorder With Depression (BD-D)NCT06656416PHASE2Alto NeuroscienceBipolar Disorder I or II With a Major Depressive EpisodeToms River, NJ
Popular conditions in New Jersey
Frequently asked questions
- How do I find clinical trials in New Jersey?
- Corterve aggregates actively recruiting clinical trials with sites in New Jersey from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in New Jersey free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in New Jersey?
- New Jersey research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.